Our choice to treat the BEAS-2B HBECs with 40 ng/mL of FGF23 was based on previous work from our lab indicating that even 25 ng/mL induces significant secretion of IL1B in bronchial epithelial cells from COPD patients16. Here, IL1B is linked to chronic obstructive pulmonary disease.